載入...

Are VEGFR-TKIs effective or safe for patients with advanced non-small cell lung cancer?

Vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) might be new therapeutic strategies for advanced non-small cell lung cancer (NSCLC). Here a total of 12,520 patients from 23 randomized controlled trials (RCTs) were enrolled to evaluate the efficacy and safety of VE...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Wang, Shuai, Yang, Zhe, Wang, Zhou
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2015
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4627246/
https://ncbi.nlm.nih.gov/pubmed/26156021
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!